These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 18679536)
1. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. Peters PH; Moscona A; Schulman KL; Barr CE Medscape J Med; 2008 Jun; 10(6):131. PubMed ID: 18679536 [TBL] [Abstract][Full Text] [Related]
2. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Orzeck EA; Shi N; Blumentals WA Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482 [TBL] [Abstract][Full Text] [Related]
3. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Blumentals WA; Schulman KL Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881 [TBL] [Abstract][Full Text] [Related]
4. Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. Gums JG; Pelletier EM; Blumentals WA Expert Opin Pharmacother; 2008 Feb; 9(2):151-61. PubMed ID: 18201141 [TBL] [Abstract][Full Text] [Related]
5. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Piedra PA; Schulman KL; Blumentals WA Pediatrics; 2009 Jul; 124(1):170-8. PubMed ID: 19564297 [TBL] [Abstract][Full Text] [Related]
6. Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006-2010. Spagnuolo PJ; Zhang M; Xu Y; Han J; Liu S; Liu J; Lichtveld M; Shi L Curr Med Res Opin; 2016 Aug; 32(8):1399-407. PubMed ID: 27052817 [TBL] [Abstract][Full Text] [Related]
7. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Barr CE; Schulman K; Iacuzio D; Bradley JS Curr Med Res Opin; 2007 Mar; 23(3):523-31. PubMed ID: 17355734 [TBL] [Abstract][Full Text] [Related]
8. Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data. Htoo PT; Measer G; Orr R; Bohn J; Sorbello A; Francis H; Dutcher SK; Cosgrove A; Carruth A; Toh S; Cocoros NM Am J Epidemiol; 2022 Mar; 191(5):908-920. PubMed ID: 35106530 [TBL] [Abstract][Full Text] [Related]
9. Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Nordstrom BL; Sung I; Suter P; Szneke P Curr Med Res Opin; 2005 May; 21(5):761-8. PubMed ID: 15969875 [TBL] [Abstract][Full Text] [Related]
10. The Impact of Immunization and Use of Oseltamivir on Influenza-Related Hospitalizations: A Population-Based Study. Athanassoglou V; Wilson LA; Liu J; Poeran J; Zhong H; Memtsoudis SG J Prim Care Community Health; 2021; 12():21501327211005906. PubMed ID: 33829910 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. Qiu S; Shen Y; Pan H; Wang J; Zhang Q Infect Dis (Lond); 2015; 47(11):808-19. PubMed ID: 26173991 [TBL] [Abstract][Full Text] [Related]
12. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons. Blumentals WA; Song X MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373 [TBL] [Abstract][Full Text] [Related]
13. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study. Vardakas KZ; Theocharis G; Tansarli GS; Rafailidis P; Falagas ME Arch Virol; 2016 Sep; 161(9):2511-8. PubMed ID: 27368992 [TBL] [Abstract][Full Text] [Related]
14. Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care. Lee JJ; Smith M; Bankhead C; Perera Salazar R; Kousoulis AA; Butler CC; Wang K Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32527739 [TBL] [Abstract][Full Text] [Related]
15. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197 [TBL] [Abstract][Full Text] [Related]
16. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments. Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583 [TBL] [Abstract][Full Text] [Related]
17. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Nordstrom BL; Oh K; Sacks ST; L'Italien GJ Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180 [TBL] [Abstract][Full Text] [Related]
18. The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza. Casscells SW; Granger E; Kress AM; Linton A Int J Adolesc Med Health; 2009; 21(1):79-89. PubMed ID: 19526698 [TBL] [Abstract][Full Text] [Related]
19. Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza. Winther B; Block SL; Reisinger K; Dutkowski R Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):684-8. PubMed ID: 20363510 [TBL] [Abstract][Full Text] [Related]
20. Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder. Wilkes JJ; Zaoutis TE; Keren R; Desai B; Leckerman KH; Hodinka RL; Metjian TA; Coffin SE J Hosp Med; 2009 Mar; 4(3):171-8. PubMed ID: 19301375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]